Bavarian Nordic A/S
Industry
- Pharmaceuticals
- Drug Delivery
- Macromolecule
- Vaccines
- Drug Delivery
- Biotechnology
- Large Molecule
Latest on Bavarian Nordic A/S
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices sprinted through a condensed two-day schedule at its 15-16 April meeting, which originally had been planne
The terms of the faceoff between the two US Food and Drug Administration-approved chikungunya vaccines shifted more favorably towards Bavarian Nordic ’s Vimkunya after the 16 April meeting of the US
The Advisory Committee on Immunization Practices’ first meeting under the Trump Administration provided an early public look at concerns that a top FDA official has about vaccine efficacy, safety and
Pandemic Anniversary Resonates Within a few days of the fifth anniversary of the declaration of the COVID-19 pandemic by the World Health Organization, the first quarter of 2025 headed towards its clo